BeiGene, Ltd. announced the appointment of Aaron Rosenberg as the principal financial officer of the Company, effective as of July 22, 2024, Mr. Rosenberg, 48, served as Senior Vice President and Corporate Treasurer at Merck & Co. Inc., from July 2021 to July 2024, responsible for capital markets, treasury operations, pension and risk management. Prior to that, he served in a variety of leadership roles of increasing scale since joining Merck in June 2003.

This included Senior Vice President of Corporate Strategy and Planning, and Vice President, Finance Lead of Merck Animal Health. During his tenure at Merck, he was responsible for corporate strategy development, strategic and financial planning, financial operations and management, among others. Mr. Rosenberg is a CFA ® charterholder and holds a B.S. in Finance from University of Florida and an M.B.A. from the Leonard N. Stern School of Business at the New York University.